Juvenile multiple sclerosis-like episodes associated with a defect of mitochondrial beta oxidation

Neurology

Volumn 40, Issue 3, 1990, Pages 487-491

  Powell, B R ^a   Kennaway, N G ^a   Rhead, W J ^b   Reece, C J ^b   Burlingame, T G ^a   Buist, N ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALMITIC ACID; RADIOISOTOPE;

ARTICLE; BRAIN DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHILD; DEMYELINATION; FATTY ACID OXIDATION; HUMAN; MITOCHONDRION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AMINO ACID METABOLISM, INBORN ERRORS; CASE REPORT; CHILD, PRESCHOOL; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; DICARBOXYLIC ACIDS; FATTY ACID DESATURASES; FEMALE; GLUTARATES; HUMAN; MITOCHONDRIA; MULTIPLE SCLEROSIS; OXYGEN CONSUMPTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025239837     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.3_part_1.487     Document Type: Article

References (28)

1. Vianey-Liaud C, Divry P, Gregersen N, Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherited Metab Dis 1987;10 (suppl 1): 159–198.
2. Howat AJ, Bennett MJ, Variend S, Shaw L, Engel PC. Defect of metabolism of fatty acids in the sudden infant death syndrome. Br Med J 1985;290:1771–1773.
3. Harpey JP, Charpentier C, Coude M, Divry P, Patumeau-Jonas M. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria or systemic carnitine deficiency. J Pediatr 1987;110:881–884.
4. Hale DE, Batshaw ML, Coates P, et al. Long chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediatr Res 1985;19:666–671.
5. Turnbull DM, Bartlett K, Stevens DL, et al. Short chain acyl-CoA dehydrogenase deficiency associated with a lipid storage myopathy and secondary carnitine deficiency. N Engl J Med 1984;311:1232–1236.
6. Taubman B, Hale DE, Kelley RI. Familial Reye-like syndrome: A presentation of medium chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 1987;79:382–385.
7. Stanley CA, Gonzala E, Yang W, Kelley RI, Baker L. Hypoketotic hypoglycemia: evidence for a new defect in fatty acid oxidation (Abstract). Pediatr Res 1982;16:264A.
8. Beckman JD, Frerman FE. Electron transfer flavoprotein ubiquinone oxidoreductase from pig liver: purification, molecular redox, and catalytic properties. Biochemistry 1985;24:3913–3921.
9. Rhead WJ, Wolff JA, Lipson M, et al. Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenase disorders. Pediatr Res 1987;21:371–376.
10. Goodman SI, McCabe ER, Fennessey PV, Mace JW. Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res 1980;14:12–17.
11. Sweetman L, Nyhan WL, Trauner DA, Merritt TA, Singh M. Glutaric aciduria type II. J Pediatr 1980;96:1020–1026.
12. Gregersen N, Kolvraa, S, Rasmussen K, et al. Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. J Inherited Metab Dis 1980;3:67–72.
13. Amendt BA, Rhead WJ. The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic acidemia. J Clin Invest 1986;78:205–213.
14. Gregersen N, Wintzensen H, Kolvraa S, etal. C6-Cl0dicarboxylic aciduria: investigation of a patient with riboflavin responsive multiple acyl CoA dehydrogrenation defect. Pediatr Res 1982;16:861–868.
15. McGarry JD, Foster DW. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976;17:277–281.
16. Roe CR, Millington DS, Maltby DA. Diagnostic and therapeutic implications of acylcarnitine profiling in organic acidurias associated with carnitine insufficiency. In: Borum PR, ed. Clinical aspects of human carnitine deficiency. New York: Pergamon Press, 1986:97–107.
17. Moon A, Rhead WJ. Complementation analysis of fatty acid oxidation disorders. J Clin Invest 1987;79:59–64.
18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis; guidelines for research proposals. Ann Neurol 1983;13:227–231.
19. Paty DW, Asbury AK, Herndon RM, et al. Use of magnetic resonance imaging in the diagnosis of multiple sclerosis: policy statement. Neurology 1986;36:1575.
20. Duquette P, Murray TJ, Pleimes J, et al. Multiple sclerosis in childhood: clinical profiles in 125 patients. J Pediatr 1987;111:359–363.
21. DiMario FJ, Berman PU. Multiple sclerosis presenting at 4 years of age: clinical and MRI correlations. Clin Pediatr 1988;27:32–37.
22. Brandt S, Glydensted C, Offner H, Melchior JC. Multiple sclerosis with onset in a two year old boy. Neuropediatrics 1958;12:75–82.
23. Schutgens RBH, Heymans HSA, Wanders RJA, Vanden Bosch J, Tager JM. Peroxisomal disorders: a newly recognized group of genetic disease. Eur J Pediatr 1986;144:430–440.
24. Reimecke CJ, Knoll DP, Pretorius PJ, et al. The correlation between biochemical and histopathological findings in adreno- leukodystrophy. J Neurol Sci 1985;70:21–38.
25. Dooley JM, Wright BA. Adrenoleukodystrophy mimicking multiple sclerosis. Can J Neurol Sci 1985;12:73–74.
26. Griffin DE, Moser HW, Mendoza Q, Moerich TR, O’Toole S, Moser AB. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann Neurol 1985;18:660–664.
27. Duran M, Walther FJ, Bruinris L, Wadman, SK. The urinary excretion of ethylmalonic acid: what level requires further attention? Biochem Med 1983;29:171–175.
28. Mortensen PRB, Gregersen N. Medium-chain triglyceride medication as a pitfall in the diagnosis of non-ketotic C6-C10 dicarboxy- lin aciduria. Clin Chim Acta 1980;103:33–37.